Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Ireland’s goods exports rose in February from a year earlier, driven by a sharp increase in medical and pharmaceutical sales, figures from the Central Statistics Office showed Tuesday.
Unadjusted exports surged by €8.7 billion, or 54%, to €24.6 billion in February from €15.9 billion a year earlier.
The growth was largely underpinned by a more than doubling in exports of medical and pharmaceutical products, which rose to €15.6 billion and accounted for over 63% of total goods exports for the month.
Seasonally adjusted trade exports grew by €700.9 million, or 2.8%, to €25.5 billion compared with January.
Imports also increased strongly, though not quite as strongly. Seasonally adjusted imports rose 14.8% from January to €12.6 billion, while unadjusted imports climbed 15% annually to €11.8 billion.
This led to a seasonally adjusted trade surplus of €12.9 billion in February, down from €13.9 billion in January.
Exports to the US more than tripled year-on-year, surging to €12.9 billion in February. This made the US Ireland’s largest trading partner by a wide margin, accounting for over half of all goods exports in February. The bulk of exports to the US - 91% - were classified under Chemicals & Related Products, which includes pharmaceuticals.
Imports of medical and pharmaceutical products also jumped, rising 84% annually to €2 billion, or 17% of total imports. Meanwhile, imports of organic chemicals fell by nearly 25% to €853 million.
Among other trading partners, exports to Great Britain were largely unchanged year-on-year at €1.2 billion, while imports from Great Britain declined 3.3% to €1.36 billion.
For the year to date, total exports for January and February combined were €50.4 billion, up 45% from the same period in 2024, while imports increased by 12% to €22.3 billion.
Copyright 2025 Alliance News Ltd. All Rights Reserved.